Chief Executive Officer · ROCKWELL MEDICAL, INC. (RMTI)

Mark Strobeck

A named executive officer of ROCKWELL MEDICAL in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,895,472

Salary $566,500Stock awards $612,040

FY2024: $1,310,878

1st of 3 named executive officers at Rockwell Medical by FY2025 total.

3 named officers on file for ROCKWELL MEDICAL, FY2025

Mark Strobeck’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ROCKWELL MEDICAL’s whole pay program stands against its peers

  • ROCKWELL MEDICAL’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on RMTI→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Mark Strobeck’s full pay file as a PDF — free

More than this page: up to 10 years of Mark’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Mark Strobeck compensation by year

ROCKWELL MEDICAL Summary Compensation Table · all 2 fiscal years held
In US dollars, as ROCKWELL MEDICAL reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025
Salary$566,500$566,500
Bonus$0$0
Stock awards$139,000$612,040
Option awards$138,378$249,732
Non-equity incentive$453,200$453,200
Pension and deferred compensation$0$0
All other$13,800$14,000
Total$1,310,878$1,895,472

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ROCKWELL MEDICAL, INC. DEF 14A filed April 30, 2026, accession 0001628280-26-028571, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ROCKWELL MEDICAL, INC. filed document, accession 0001628280-26-028571. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.

$1.3M
$1.9M
FY24
FY25
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
PSU352,000$292,160—
RSU220,000$182,600—
RSU66,667$55,334—
Option308,000—$1.07
Option79,628—$1.39
Option24,096—$1.37
Option100,000—$1.28

Per the Outstanding Equity Awards at Fiscal Year-End table in ROCKWELL MEDICAL, INC.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

2 Form 4 lines since the FY2025 proxy (filed April 30, 2026)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-10-01Sale10b5-11,000$8.4261,349
2026-07-01Grant or award—30,000$0.0062,349

The 2 most recent of 2 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

ROCKWELL MEDICAL’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Mark Strobeck · this pageChief Executive Officer$1,895,472
Megan TimminsChief Legal Officer and Secretary$978,159
Jesse NeriChief Financial Officer$828,809

The full ROCKWELL MEDICAL compensation record

free company brief

This page is one person within ROCKWELL MEDICAL's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ROCKWELL MEDICAL's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Mark Strobeck's compensation dossier · One-time report. No refunds.